Home Journals The Effect of Omega-3 Supplementation on Serum Levels of Inflammatory Biomarkers and Albumin in Hemodialysis Patients: A Systematic Review and Meta-analysis

The Effect of Omega-3 Supplementation on Serum Levels of Inflammatory Biomarkers and Albumin in Hemodialysis Patients: A Systematic Review and Meta-analysis

Credits to the Source Link Obum
The Effect of Omega-3 Supplementation on Serum Levels of Inflammatory Biomarkers and Albumin in Hemodialysis Patients: A Systematic Review and Meta-analysis
  • U S Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, Maryland. 2017;2:337-350.

    • de Jager D.J.
    • Grootendorst D.C.
    • Jager K.J.
    • et al.

    Cardiovascular and noncardiovascular mortality among patients starting dialysis.

    JAMA. 2009; 302: 1782-1789

  • Cardiovascular mortality in end-stage renal disease.

    Am J Med Sci. 2003; 325: 163-167

  • Clinical epidemiology of cardiovascular disease in chronic kidney disease.

    J Ren Care. 2010; 36: 4-8

    • Fellström B.C.
    • Jardine A.G.
    • Schmieder R.E.
    • et al.

    Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

    New Engl J Med. 2009; 360: 1395-1407

    • Wanner C.
    • Krane V.
    • März W.
    • et al.

    Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

    New Engl J Med. 2005; 353: 238-248

    • Palmer S.C.
    • Mavridis D.
    • Navarese E.
    • et al.

    Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.

    Lancet. 2015; 385: 2047-2056

    • Zimmermann J.
    • Herrlinger S.
    • Pruy A.
    • Metzger T.
    • Wanner C.

    Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

    Kidney Int. 1999; 55: 648-658

    • Wanner C.
    • Zimmermann J.
    • Schwedler S.
    • Metzger T.

    Inflammation and cardiovascular risk in dialysis patients.

    Kidney Int. 2002; 61: S99-S102

    • Danielski M.
    • Ikizler T.A.
    • McMonagle E.
    • et al.

    Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy.

    Am J Kidney Dis. 2003; 42: 286-294

    • Bologa R.M.
    • Levine D.M.
    • Parker T.S.
    • et al.

    Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

    Am J kidney Dis. 1998; 32: 107-114

    • Qureshi A.R.
    • Alvestrand A.
    • Danielsson A.
    • et al.

    Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.

    Kidney Int. 1998; 53: 773-782

    • He L.
    • Li M.S.
    • Lin M.
    • Zhao T.Y.
    • Gao P.

    Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials.

    Eur J Clin Pharmacol. 2016; 72: 129-139

    • Kalantar-Zadeh K.
    • Tortorici A.R.
    • Chen J.L.
    • et al.

    Dietary restrictions in dialysis patients: is there anything left to eat?.

    InSeminars Dial. 2015; 28: 159-168

    • Salehi Y.
    • Moinzadeh F.
    • Mortazavi M.
    • Hoseini M.
    • Dolatkhah S.
    • Taheri S.
    • Salehi A.

    The Effect of Omega-3 Supplementation on Serum Inflammatory Factors in Hemodialysis Patients.

    BJMMR. 2017; 20: 1-7

    • Moeinzadeh F.
    • Shahidi S.
    • Mortazavi M.
    • et al.

    Effects of omega-3 fatty acid supplementation on serum biomarkers, inflammatory agents, and quality of life of patients on hemodialysis.

    Iranian J kidney Dis. 2016; 10: 381

    • Gharekhani A.
    • Khatami M.R.
    • Dashti-Khavidaki S.
    • et al.

    The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.

    Eur J Clin Pharmacol. 2014; 70: 655-665

    • Bowden R.G.
    • Wilson R.L.
    • Deike E.
    • Gentile M.

    Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.

    Nutr Clin Pract. 2009; 24: 508-512

    • Saifullah A.
    • Watkins B.A.
    • Saha C.
    • Li Y.
    • Moe S.M.
    • Friedman A.N.

    Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients—a pilot study.

    Nephrol Dial Transplant. 2007; 22: 3561-3567

    • Asemi Z.
    • Soleimani A.
    • Shakeri H.
    • Mazroii N.
    • Esmaillzadeh A.

    Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition–inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients.

    Int Urol Nephrol. 2016; 48: 1887-1895

    • Hung A.M.
    • Booker C.
    • Ellis C.D.
    • et al.

    Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients.

    Nephrol Dial Transplant. 2014; 30: 266-274

    • Kooshki A.
    • Taleban F.A.
    • Tabibi H.
    • Hedayati M.

    Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients.

    Ann Nutr Metab. 2011; 58: 197-202

    • Eide I.A.
    • Åsberg A.
    • Svensson M.
    • et al.

    Plasma levels of marine n-3 fatty acids are inversely correlated with proinflammatory markers sTNFR1 and IL-6 in renal transplant recipients.

    J Ren Nutr. 2017; 27: 161-168

    • de Mattos A.M.
    • da Costa J.A.
    • Júnior A.A.
    • Chiarello P.G.

    Omega-3 fatty acid supplementation is associated with oxidative stress and dyslipidemia, but does not contribute to better lipid and oxidative status on hemodialysis patients.

    J Ren Nutr. 2017; 27: 333-339

    • Hu C.
    • Yang M.
    • Zhu X.
    • et al.

    Effects of omega-3 fatty acids on markers of inflammation in patients with chronic kidney disease: a controversial issue.

    Ther Apher Dial. 2018; 22: 124-132

    • Himmelfarb J.
    • Phinney S.
    • Ikizler T.A.
    • Kane J.
    • McMonagle E.
    • Miller G.

    Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.

    J Ren Nutr. 2007; 17: 296-304

    • Daud Z.A.
    • Tubie B.
    • Adams J.
    • et al.

    Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.

    Vasc Health Risk Manag. 2012; 8: 187

    • Higgins J.P.
    • Altman D.G.
    • Gøtzsche P.C.
    • et al.

    The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.

    BMJ. 2011; 343: d5928

    • Elbourne D.R.
    • Altman D.G.
    • Higgins J.P.
    • Curtin F.
    • Worthington H.V.
    • Vail A.

    Meta-analyses involving cross-over trials: methodological issues.

    Int J Epidemiol. 2002; 31: 140-149

    • Higgins J.P.
    • Thompson S.G.
    • Deeks J.J.
    • Altman D.G.

    Measuring inconsistency in meta-analyses.

    BMJ (Clinical research ed). 2003; 327: 557-560

  • A measure to aid in the interpretation of published clinical trials.

    Stat Med. 1985; 4: 1-9

    • Kalantar-Zadeh K.
    • Ikizler T.A.
    • Block G.
    • Avram M.M.
    • Kopple J.D.

    Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences.

    Am J kidney Dis. 2003; 42: 864-881

  • Source Link

    Related Posts

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: